In agreement with these findings, the suppression of UBE2Ds inhibits MDM2-mediated p53 ubiquitination, consequently increasing apoptosis and significantly inhibiting the proliferation of human lung cancer cells in a p53-dependent manner [92]. The gene discussed is TP53; the disease is lung carcinoma.